Patients News | pharmaphorum

News

Study backs safety of Gilead CAR-T as outpatient therapy

CAR-T therapies can achieve remarkable efficacy in the treatment of haematological cancers, but the risk of side effects means that the cell infusions are almost always ad

News

Innsena backs CancerX’s digital drive to improve access

Healthtech consultancy Innsena has committed funding and expertise to The White House’s CancerX initiative, launched last year to encourage the use of digital technologies

News

Exercise ‘may be better than drugs for depression’

Doctors should think twice before prescribing drug therapies when faced with someone battling depression, as exercise may be more effective, according to a new study.

News

UK patients very concerned about access to diagnostics

Almost two-thirds of patients in the UK would consider paying for diagnostics out of pocket if they face a long wait for free NHS testing, and almost all want to see more

News

Biomarkers ‘may predict dementia 15 years before diagnosis’

Researchers in the UK and China have used proteomics data from the UK Biobank to identify protein biomarkers in the blood that could give warning of dementia years before

News

Apple devices enrich patent data in arthritis trial

It can be challenging to follow the course of rheumatoid arthritis accurately in clinical assessments and trials due to “subtle and unpredictable” changes in symptoms – bu

Study backs safety of Gilead CAR-T as outpatient therapy

Innsena backs CancerX’s digital drive to improve access

Exercise ‘may be better than drugs for depression’

UK patients very concerned about access to diagnostics

Biomarkers ‘may predict dementia 15 years before diagnosis’

Apple devices enrich patent data in arthritis trial

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

News

Editor's Picks